ºÚÁÏÍø

ISSN: 2165-7386

Journal of Palliative Care & Medicine
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

Toronto, Canada

Toronto, Canada
Citations : 2035

Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Effectiveness of one year pharmacotherapy of adults with attention-deficit hyperactivity disorder (ADHD): An open-label prospective study of treatment time, dose, side-effects and comorbidity

International Conference on Hospice & Palliative Care

Dawn Peleikis

Akershus University Hospital, Norway

ScientificTracks Abstracts: J Palliat Care Med

DOI:

Abstract
The aim of this study was to examine clinical relevance of long-term medication of adult ADHD. Electronic databases reviewed for original studies of long-term pharmacotherapy suggested that medication leads to less symptoms and higher functional outcomes compared to non-treatment and was well tolerated. However, the literature was scarce and had limitations in generalizing the outcome to the ADHD patients in general. The original studies of the thesis were conducted on 250 medication-na�¯ve adult ADHD-patients at a specialized outpatient clinic. Higher levels of childhood hyperactive-impulsive symptoms and overall severity of ADHD-symptoms were associated with educational failure. Persisting inattentive symptoms and co-morbid mental disorders in adulthood were related to long term work disability. In the observational prospective part of the clinical study patients were treated with current ADHD-medication. At 12-months follow-up 232 patients completed examination, and 70% persisted on medication. Sustained improvement of symptoms and functioning were related to continued medication. Co-morbid mental disorders and side-effects were related to lower effectiveness and adherence. Hyperactiveimpulsive ADHD-symptoms and severity of ADHD-symptoms in childhood was related to not having completed secondary school. Sustained attention difficulties in adulthood and comorbidity of psychiatric disorders were related to long-term work incapacity. Maintained use of ADHD medications was associated with significant reduction of ADHD-symptoms, improvement in general functioning and psychological symptoms. No serious adverse events were recorded.
Biography

Dawn Peleikis in 1994, started as a resident in psychiatry. She became an authorized psychiatrist in 1999. She completed her education in psychotherapy at the Norwegian Institute of Psychotherapy. In 2000-2004, she did her PhD work and her dissertation was on “Women who were sexually abused as children: Aspects and functioning after therapy”. From 2005 she worked both on clinical and research associated to Department of Research and Development, Department of Psychiatry, Akershus University Hospital. Her topics of research have been: trauma/PTSD, Schizophrenia and ADHD. She was the main supervisor in the PhD work of MD Fredriksen and is doing effectiveness study on adult ADHD-patients.

Email: dawn.peleikis@vikenfiber.no

Relevant Topics
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top